Market
Boston Scientific and Blackstone agree on $455m VITALYST heart pump deal
Boston Scientific and Blackstone Life Sciences announced a $455 million co-funding partnership to develop the VITALYST heart pump program. The collaboration combines Boston Scientific's cardiovascular expertise with Blackstone's investment capital to advance the left ventricular assist device candidate through clinical development and commercialization.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network